Akèy › ALS ak Maladi Neuròn Motor › Maryland
Etid klinik pou ALS ak Maladi Neuròn Motor nan Maryland
7 etid pou ALS ak Maladi Neuròn Motor ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT07204977Study of Inherited Neurological Disorders
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 2 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00004568Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteVolontè an sante akeyi
Laj 2 a 110 · Tout sèks · Mizajou Sep 28, 2026 · NCT01900132Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Sep 17, 2026 · NCT03225144Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Gason · Mizajou Aug 13, 2026 · NCT04944940Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
- TidalHealth Peninsula Regional, Inc., Salisbury
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT07491484Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Johns Hopkins Medicine Brain Science Institute, Baltimore
Ap rekriteFaz 3
Laj 18 a 81 · Tout sèks · Mizajou Sep 12, 2025 · NCT03127267Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.